Form 4: 10x Genomics CFO Sells Shares for Tax Obligations

10x Genomics' Chief Financial Officer, Adam Taich, sold 11,888 shares of Class A Common Stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Adam Taich, Chief Financial Officer of 10x Genomics, Inc. (TXG), reported a transaction involving company stock.
• On November 24, 2025, Mr. Taich disposed of 11,888 shares of Class A Common Stock.
• The shares were sold at a price of $18.9983 per share.
• This sale was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following this transaction, Mr. Taich beneficially owns 297,385 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, tax-related sale of shares following RSU vesting, which is a neutral event and does not indicate a change in management's outlook on the company.

Future Outlook

N/A

Industry Context

This filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends. It reflects a standard compensation-related event for an executive at a biotechnology tools company.

Stakeholder Impact

• The impact on shareholders is minimal as this is a routine, tax-related sale by an executive, not indicative of a change in company fundamentals or management confidence.

Key Dates

Recommendation

The filing details a routine, tax-related sale of shares by the CFO to cover RSU vesting obligations. This type of transaction is common and generally not indicative of a change in the company's fundamentals or the executive's long-term confidence. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

10x Genomics, TXG, Adam Taich, CFO, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding